IP Verse

Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp competitive analysis

Latest oppositions filed by Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp

Explore patent oppositions filed by Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3210965
Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolGRNENTHALAug 17, 2022
EP3366283
Direct Compression Formulation And ProcessNOVARTISMay 23, 2022
EP2667856
Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active IngredientOTSUKA PHARMACEUTICALApr 21, 2022
EP2341905
Sustained Release Formulations Using Non-Aqueous CarriersAMYLIN PHARMACEUTICALSJan 28, 2021
EP2094246
Sustained-Release Composition And Method For Producing The SameTAKEDA PHARMACEUTICALDec 16, 2020
EP3280416
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 1, 2020
EP3042646
Pharmaceutical Compositions Having Desirable BioavailabilityALCON RESEARCHFeb 1, 2018

Latest PTAB cases involving Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp

Discover the latest PTAB cases involving Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INSTONE, TERRY/READ, HOWARD GRAHAM/APPLEYARD LEES IP LLP9 - - -
NOVARTIS6467 - 21
OTSUKA PHARMACEUTICAL - 27 - 1
TAKEDA PHARMACEUTICAL126 - 1